4.5 Article

The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests

Journal

JOURNAL OF ALZHEIMERS DISEASE
Volume 51, Issue 4, Pages 1145-1155

Publisher

IOS PRESS
DOI: 10.3233/JAD-150729

Keywords

Alzheimer's disease; cognitive change index; cognitive performance; subjective cognitive decline; validation

Categories

Funding

  1. NIH [P30 AG10133, R01 AG19771, R01 LM011360, R00 LM011384, R01 AG040770, R01 AG045157, K01 AG049050, K02 AG048240]
  2. Indiana CTSI (NIH) [U54 RR025761, RR027710-01, RR020128]
  3. Alzheimer's Association
  4. Indiana University Health-Indiana University School of Medicine Strategic Research Initiative
  5. NSF [IIS-1117335]
  6. Faculty of Medicine, Siriraj Hospital, Mahidol University
  7. Indiana University School of Medicine, Indianapolis, IN, USA
  8. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER
  9. NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027710, C06RR020128, UL1RR025761] Funding Source: NIH RePORTER
  10. NATIONAL INSTITUTE ON AGING [P30AG010133, R01AG045157, K02AG048240, R01AG019771, K01AG049050, R01AG040770] Funding Source: NIH RePORTER
  11. NATIONAL LIBRARY OF MEDICINE [R00LM011384, R01LM011360] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Background: The perception of cognitive decline by individuals and those who know them well (informants) has been inconsistently associated with objective cognitive performance, but strongly associated with depressive symptoms. Objective: We investigated associations of self-report, informant-report, and discrepancy between self-and informant-report of cognitive decline obtained from the Cognitive Change Index (CCI) with cognitive test performance and self-reported depressive symptoms. Methods: 267 participants with normal cognition, mild cognitive impairment (MCI), or mild dementia were included from a cohort study and memory clinic. Association of test performance and self-rated depression (Geriatric Depression Scale, GDS) with CCI scores obtained from subjects (CCI-S), their informants (CCI-I), and discrepancy scores between subjects and informants (CCI-D; CCI-S minus CCI-I) were analyzed using correlation and analysis of covariance (ANCOVA) models. Results: CCI-S and CCI-I scores showed high internal consistency (Cronbach alpha 0.96 and 0.98, respectively). Higher scores on CCI-S and CCI-I, and lower scores on the CCI-D, were associated with lower performance on various cognitive tests in both univariate and in ANCOVA models adjusted for age, gender, and education. Adjustment for GDS slightly weakened the relationships between CCI and test performance but most remained significant. Conclusion: Self-and informant-report of cognitive decline, as measured by the CCI, show moderately strong relationships with objective test performance independent of age, gender, education, and depressive symptoms. The CCI appears to be a valid cross-sectional measure of self and informant perception of cognitive decline across the continuum of functioning. Studies are needed to address the relationship of CCI scores to longitudinal outcome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies

Tingting Wang, Kevin Huynh, Corey Giles, Natalie A. Mellett, Thy Duong, Anh Nguyen, Wei Ling Florence Lim, Alex A. T. Smith, Gavriel Olshansky, Gemma Cadby, Joseph Hung, Jennie Hui, John Beilby, Gerald F. Watts, Pratishtha Chatterjee, Ian Martins, Simon M. Laws, Ashley Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, Kevin Taddei, Vincent Dore, Juergen Fripp, Matthias Arnold, Gabi Kastenmueller, Kwangsik Nho, Andrew J. Saykin, Rebecca Baillie, Xianlin Han, Ralph N. Martins, Eric K. Moses, Rima Kaddurah-Daouk, Peter J. Meikle

Summary: The APOE genotype is strongly associated with late-onset Alzheimer's disease, with specific lipid species mediating up to 30% and 10% of the treatment effect of APOE epsilon 2 and epsilon 4, respectively. Plasma lipid species represent a potential therapeutic target for Alzheimer's disease.

ALZHEIMERS & DEMENTIA (2022)

Article Clinical Neurology

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum

Duygu Tosun, Zeynep Demir, Dallas P. Veitch, Daniel Weintraub, Paul Aisen, Clifford R. Jack, William J. Jagust, Ronald C. Petersen, Andrew J. Saykin, Leslie M. Shaw, John Q. Trojanowski, Michael W. Weiner

Summary: Aβ, tau, and neurodegeneration have significant impacts on cognitive impairment and cognitive decline, while AD risk factors also play an important role in affecting disease progression.

ALZHEIMERS & DEMENTIA (2022)

Article Clinical Neurology

Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease

Emrin Horgusluoglu, Ryan Neff, Won-Min Song, Minghui Wang, Qian Wang, Matthias Arnold, Jan Krumsiek, Beatriz Galindo-Prieto, Chen Ming, Kwangsik Nho, Gabi Kastenmueller, Xianlin Han, Rebecca Baillie, Qi Zeng, Shea Andrews, Haoxiang Cheng, Ke Hao, Alison Goate, David A. Bennett, Andrew J. Saykin, Rima Kaddurah-Daouk, Bin Zhang

Summary: This study aims to identify AD-specific metabolomic changes and their potential upstream genetic and transcriptional regulators through an integrative systems biology framework. The findings suggest that short-chain acylcarnitines/amino acids and medium/long-chain acylcarnitines are most associated with AD clinical outcomes. Integration of gene expression data reveals ABCA1 and CPT1A are involved in regulating acylcarnitines and amino acids in AD.

ALZHEIMERS & DEMENTIA (2022)

Article Neurosciences

Integrative Co-methylation Network Analysis Identifies Novel DNA Methylation Signatures and Their Target Genes in Alzheimer?s Disease

Jun Pyo Kim, Bo-Hyun Kim, Paula J. Bice, Sang Won Seo, David A. Bennett, Andrew J. Saykin, Kwangsik Nho

Summary: Through analysis of data from two independent cohorts, we found that DNA methylation alterations may be involved in Alzheimer's disease (AD), and identified 15 key CpG sites associated with AD pathology.

BIOLOGICAL PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning

Jari Lahti, Samuli Tuominen, Qiong Yang, Giulio Pergola, Shahzad Ahmad, Najaf Amin, Nicola J. Armstrong, Alexa Beiser, Katharina Bey, Joshua C. Bis, Eric Boerwinkle, Jan Bressler, Archie Campbell, Harry Campbell, Qiang Chen, Janie Corley, Simon R. Cox, Gail Davies, Philip L. De Jager, Eske M. Derks, Jessica D. Faul, Annette L. Fitzpatrick, Alison E. Fohner, Ian Ford, Myriam Fornage, Zachary Gerring, Hans J. Grabe, Francine Grodstein, Vilmundur Gudnason, Eleanor Simonsick, Elizabeth G. Holliday, Peter K. Joshi, Eero Kajantie, Jaakko Kaprio, Pauliina Karell, Luca Kleineidam, Maria J. Knol, Nicole A. Kochan, John B. Kwok, Markus Leber, Max Lam, Teresa Lee, Shuo Li, Anu Loukola, Tobias Luck, Riccardo E. Marioni, Karen A. Mather, Sarah Medland, Saira S. Mirza, Mike A. Nalls, Kwangsik Nho, Adrienne O'Donnell, Christopher Oldmeadow, Jodie Painter, Alison Pattie, Simone Reppermund, Shannon L. Risacher, Richard J. Rose, Vijay Sadashivaiah, Markus Scholz, Claudia L. Satizabal, Peter W. Schofield, Katharina E. Schraut, Rodney J. Scott, Jeannette Simino, Albert V. Smith, Jennifer A. Smith, David J. Stott, Ida Surakka, Alexander Teumer, Anbupalam Thalamuthu, Stella Trompet, Stephen T. Turner, Sven J. van der Lee, Arno Villringer, Uwe Voelker, Robert S. Wilson, Katharina Wittfeld, Eero Vuoksimaa, Rui Xia, Kristine Yaffe, Lei Yu, Habil Zare, Wei Zhao, David Ames, John Attia, David A. Bennett, Henry Brodaty, Daniel I. Chasman, Aaron L. Goldman, Caroline Hayward, M. Arfan Ikram, J. Wouter Jukema, Sharon L. R. Kardia, Todd Lencz, Markus Loeffler, Venkata S. Mattay, Aarno Palotie, Bruce M. Psaty, Alfredo Ramirez, Paul M. Ridker, Steffi G. Riedel-Heller, Perminder S. Sachdev, Andrew J. Saykin, Martin Scherer, Peter R. Schofield, Stephen Sidney, John M. Starr, Julian Trollor, William Ulrich, Michael Wagner, David R. Weir, James F. Wilson, Margaret J. Wright, Daniel R. Weinberger, Stephanie Debette, Johan G. Eriksson, Thomas H. Mosley, Lenore J. Launer, Cornelia M. van Duijn, Ian J. Deary, Sudha Seshadri, Katri Raikkonen

Summary: This study examines the associations between genetic variants and verbal short-term memory and learning in adults, revealing several genomic loci that are implicated in these processes. Functional and bioinformatic analyses support these findings, while genetic correlations with neurocognitive and health outcomes further highlight the significance of these memory traits.

MOLECULAR PSYCHIATRY (2022)

Article Clinical Neurology

Biomarkers for dementia in Latin American countries: Gaps and opportunities

Mario A. Parra, Paulina Orellana, Tomas Leon, Cabello G. Victoria, Fernando Henriquez, Rodrigo Gomez, Constanza Avalos, Andres Damian, Andrea Slachevsky, Agustin Ibanez, Henrik Zetterberg, Betty M. Tijms, Jennifer S. Yokoyama, Stefanie D. Pina-Escudero, J. Nicholas Cochran, Diana L. Matallana, Daisy Acosta, Ricardo Allegri, Bianca P. Arias-Suarez, Bernardo Barra, Maria Isabel Behrens, SoniaM. D. Brucki, Geraldo Busatto, Paulo Caramelli, Sheila Castro-Suarez, Valeria Contreras, Nilton Custodio, Sergio Dansilio, Myriam De la Cruz-Puebla, Leonardo Cruz de Souza, Monica M. Diaz, Lissette Duque, Gonzalo A. Farias, Sergio T. Ferreira, Nahuel Magrath Guimet, Ana Kmaid, David Lira, Francisco Lopera, Beatriz Mar Meza, Eliane C. Miotto, Ricardo Nitrini, Alberto Nunez, Santiago O'Neill, John Ochoa, Maritza Pintado-Caipa, Elisa de Paula Franca Resende, Shannon Risacher, Luz Angela Rojas, Valentina Sabaj, Lucas Schilling, Allis F. Sellek, Ana Sosa, Leonel T. Takada, Antonio L. Teixeira, Martha Unaucho-Pilalumbo, Claudia Duran-Aniotz

Summary: Limited knowledge and funding, as well as inadequate infrastructure, present significant barriers to dementia biomarker research in Latin American and Caribbean countries. However, the region shows great potential for advancements in this field.

ALZHEIMERS & DEMENTIA (2023)

Review Neuroimaging

Altered cerebral blood flow in older adults with Alzheimer's disease: a systematic review

Cecily G. Swinford, Shannon L. Risacher, Yu-Chien Wu, Liana G. Apostolova, Sujuan Gao, Paula J. Bice, Andrew J. Saykin

Summary: The prevalence of Alzheimer's disease in the U.S. is expected to reach 13 million by 2050. Currently, there are no treatments available to stop or reverse the progressive cognitive decline associated with the disease. Preventive treatment before significant cognitive decline occurs may be the solution, but there is a need for a reliable biomarker to identify older adults at highest risk. Quantitative cerebral blood flow shows promise as a potential early biomarker for Alzheimer's disease, but further research is needed to fully understand the patterns of altered blood flow.

BRAIN IMAGING AND BEHAVIOR (2023)

Letter Clinical Neurology

Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific

Jung-Min Pyun, Young Ho Park, Jiebiao Wang, Paula J. Bice, David A. Bennett, SangYun Kim, Andrew J. Saykin, Kwangsik Nho

ANNALS OF NEUROLOGY (2023)

Article Oncology

Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls †

Kelly Nudelman, Kwangsik Nho, Michael Zhang, Brenna C. McDonald, Wanting Zhai, Brent J. Small, Claire E. Wegel, Paul B. Jacobsen, Heather S. L. Jim, Sunita K. Patel, Deena M. A. Graham, Tim A. Ahles, James C. Root, Tatiana Foroud, Elizabeth C. Breen, Judith E. Carroll, Jeanne S. Mandelblatt, Andrew J. Saykin

Summary: This study found that genetics may play an important role in modifying risk for cognitive decline in older female breast cancer survivors. Several genetic variants and genes were identified to be associated with differences in patterns of cognitive decline in cancer patients compared to controls. Further research and validation of these findings in other cancer populations is necessary to inform therapeutic research and evaluations of risk for cognitive decline in older cancer survivors.

CANCERS (2023)

Article Biophysics

Paravascular fluid dynamics reveal arterial stiffness assessed using dynamic diffusion-weighted imaging

Qiuting Wen, Adam Wright, Yunjie Tong, Yi Zhao, Shannon L. Risacher, Andrew J. Saykin, Yu-Chien Wu, Kaustubh Limaye, Kalen Riley

Summary: This study used dynamic diffusion-weighted imaging (dynDWI) to investigate the pulsatile dynamics of paravascular cerebrospinal fluid (pCSF) and revealed a strong correlation between pCSF pulse and finger pulse. The study also found that the time delay between pCSF and finger pulses decreased with age and shorter time delay was associated with worse cognitive function in older individuals.

NMR IN BIOMEDICINE (2023)

Article Cell Biology

A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease

Rafi Haque, Caroline M. Watson, Jiaqi Liu, E. Kathleen Carter, Duc M. Duong, James J. Lah, Aliza P. Wingo, Blaine R. Roberts, Erik C. B. Johnson, Andrew J. Saykin, Leslie M. Shaw, Nicholas T. Seyfried, Thomas S. Wingo, Allan I. Levey

Summary: This study developed a reliable and high-throughput mass spectrometry assay to detect 48 key proteins in cerebrospinal fluid (CSF), and found that this panel of proteins performed at least as well as existing biomarkers in predicting clinical diagnosis, brain imaging results, cognitive decline, and dementia severity in Alzheimer's disease. Combining this panel with existing biomarkers significantly improved diagnostic accuracy and prediction of disease progression.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Genetics & Heredity

Genome-Wide Association Analysis across Endophenotypes in Alzheimer's Disease: Main Effects and Disease Stage-Specific Interactions

Thea J. Rosewood, Kwangsik Nho, Shannon L. Risacher, Sujuan Gao, Li Shen, Tatiana Foroud, Andrew J. Saykin

Summary: The genetic susceptibility for Alzheimer's disease (AD) is not fully understood. This study used an endophenotype approach to identify genetic associations and discovered novel genetic loci related to AD. These findings provide deeper insights into the genetic mechanisms underlying AD.

GENES (2023)

Article Sport Sciences

Gene Expression Alterations in Peripheral Blood Following Sport-Related Concussion in a Prospective Cohort of Collegiate Athletes: A Concussion Assessment, Research and Education (CARE) Consortium Study

Edward Simpson, Jill L. Reiter, Jie Ren, Zhiqi Zhang, Kelly N. Nudelman, Larry D. Riggen Jr, Michael D. Menser, Jaroslaw Harezlak, Tatiana M. Foroud, Andrew J. Saykin, Alison Brooks, Kenneth L. Cameron, Stefan M. Duma, Gerald Mcginty, Steven Rowson, Steven J. Svoboda, Steven P. Broglio, Michael A. McCrea, Paul F. Pasquina, Thomas W. Mcallister, Yunlong Liu, CARE Consortium Investigators

Summary: This study analyzed the gene expression changes in peripheral blood following concussion in collegiate athletes. The results showed immediate activation of cytokine and immune response signaling pathways, which later seemed to be suppressed. Additionally, the study found an increase in neutrophils and a decrease in natural killer cells in the blood following concussion.

SPORTS MEDICINE (2023)

Article Clinical Neurology

Biomarkers for dementia in Latin American countries: Gaps and opportunities

Mario A. Parra, Paulina Orellana, Tomas Leon, Cabello G. Victoria, Fernando Henriquez, Rodrigo Gomez, Constanza Avalos, Andres Damian, Andrea Slachevsky, Agustin Ibanez, Henrik Zetterberg, Betty M. Tijms, Jennifer S. Yokoyama, Stefanie D. Pina-Escudero, J. Nicholas Cochran, Diana L. Matallana, Daisy Acosta, Ricardo Allegri, Bianca P. Arias-Suarez, Bernardo Barra, Maria Isabel Behrens, SoniaM. D. Brucki, Geraldo Busatto, Paulo Caramelli, Sheila Castro-Suarez, Valeria Contreras, Nilton Custodio, Sergio Dansilio, Myriam De la Cruz-Puebla, Leonardo Cruz de Souza, Monica M. Diaz, Lissette Duque, Gonzalo A. Farias, Sergio T. Ferreira, Nahuel Magrath Guimet, Ana Kmaid, David Lira, Francisco Lopera, Beatriz Mar Meza, Eliane C. Miotto, Ricardo Nitrini, Alberto Nunez, Santiago O'Neill, John Ochoa, Maritza Pintado-Caipa, Elisa de Paula Franca Resende, Shannon Risacher, Luz Angela Rojas, Valentina Sabaj, Lucas Schilling, Allis F. Sellek, Ana Sosa, Leonel T. Takada, Antonio L. Teixeira, Martha Unaucho-Pilalumbo, Claudia Duran-Aniotz

Summary: Limited knowledge on dementia biomarkers in Latin American and Caribbean countries due to lack of funding, infrastructure, and training. However, the region holds great potential to advance dementia biomarkers research and it is crucial to expand research in this field.

ALZHEIMERS & DEMENTIA (2023)

No Data Available